Investment Focus
Diversifying Our Portfolio across Stage and Sector
Employing our operational/mentoring and venture experience and utilizing our multi-state network, we are typically the first institutional investors into deals that have graduated from angel groups or accelerators. Investments are concentrated in early-stage deals, with consideration for exceptional seed deals with an acceptable time to exit and opportunistic later-stage deals.
Applying Domain Expertise in Life Sciences and Technology
Investments are diversified across sector with focus in areas of core competency – the life sciences and technology markets – although the Fund will also maintain some investments in related technology markets where partners can bring significant domain expertise and offer more value than capital alone. Life sciences deals, which are typically slower to mature but offer larger returns, are balanced by quicker-to-exit technology deals, with sometimes smaller returns.
Investment Sector
Targeted life sciences investments include:
• Medical Devices
• Class I or II devices or Class III w/ 510K
• Diagnostic instruments/supplies
• High-throughput screening
• Selected Therapeutics
• New indications for approved therapeutics
• Novel drug delivery systems
• Healthcare IT
• Logistics
• Patient safety systems
• Patient communities
Targeted technology investments include:
• Analytics and business intelligence
• Greentech and energy
• Transportation and logistics
• Human capital management
• Advanced manufacturing
Investment Strategy
Deal Stage
Early-stage opportunities focused around unique intellectual property, specifically those that have graduated from angel investments, incubators and/or accelerators
Investment Size
Initial investments will typically range from $1-3 million, plus follow-on investments
Geographic Focus
Midwest United States, including Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Ohio, Wisconsin and Arkansas
